IRIS - Res&Arch Institutional Research Information System - Research & Archive

BASILEO, Michela
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.702
EU - Europa 1.097
AS - Asia 676
SA - Sud America 5
AF - Africa 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.483
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.641
IE - Irlanda 324
UA - Ucraina 299
SG - Singapore 184
VN - Vietnam 165
HK - Hong Kong 164
IT - Italia 114
FI - Finlandia 94
CN - Cina 83
DE - Germania 73
SE - Svezia 58
CA - Canada 56
RU - Federazione Russa 55
TR - Turchia 37
KR - Corea 26
BE - Belgio 21
GB - Regno Unito 15
LB - Libano 12
CH - Svizzera 9
FR - Francia 9
PL - Polonia 6
AT - Austria 5
CZ - Repubblica Ceca 4
MX - Messico 4
NL - Olanda 4
UZ - Uzbekistan 4
BR - Brasile 2
ES - Italia 2
GR - Grecia 2
PE - Perù 2
AR - Argentina 1
AU - Australia 1
EU - Europa 1
GH - Ghana 1
GL - Groenlandia 1
IN - India 1
NO - Norvegia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.483
Salva come PNG Salva come JPEG
Città #
Chandler 397
Dublin 324
Jacksonville 166
San Mateo 166
Dong Ket 165
Hong Kong 164
Singapore 153
Boardman 82
Santa Clara 73
Medford 71
Princeton 71
Ann Arbor 70
Ottawa 55
Andover 49
Beijing 45
Wilmington 42
Izmir 37
Ashburn 28
Helsinki 23
Perugia 22
Saint Petersburg 21
Altamura 16
Norwalk 15
Dongjak-gu 14
Genoa 13
Lawrence 13
Brussels 12
Des Moines 12
Munich 12
Falls Church 11
Seoul 10
Redwood City 9
Longueville 6
Houston 5
Redmond 5
New York 4
Bastia umbra 3
Belfiore 3
Den Haag 3
Heusden 3
Moscow 3
Padova 3
Pozzallo 3
Sona 3
Woodbridge 3
Yorktown 3
Amelia 2
Auburn Hills 2
Bologna 2
Cuernavaca 2
Faenza 2
Fortaleza 2
Lima 2
Montenero di Bisaccia 2
Naples 2
Pistoia 2
Rome 2
Sacheon-si 2
San Paolo di Civitate 2
Santa Maria Imbaro 2
Terni 2
Turin 2
Andra 1
Bratislava 1
Brno 1
Bucharest 1
Buenos Aires 1
Creazzo 1
Dallas 1
Dearborn 1
Falkenstein 1
Figline Valdarno 1
Florence 1
Frankfurt Am Main 1
Hamilton 1
Hangzhou 1
Lausanne 1
Lenzburg 1
Los Angeles 1
L’Aquila 1
Madrid 1
Melbourne 1
Messina 1
Mexico City 1
Milan 1
Muenster 1
Nanchang 1
Napoli 1
Newark 1
Nuuk 1
Oslo 1
Pescara 1
San Diego 1
Sandston 1
Seattle 1
Shanghai 1
Springfield 1
Stockholm 1
Tempio Pausania 1
Warsaw 1
Totale 2.481
Salva come PNG Salva come JPEG
Nome #
Diagnosi molecolare di sepsi: impiego della PCR Real-Time 93
Antibody response and protection after intradermal and intramuscular 2011/2012 trivalent influenza vaccination in elderly volunteers 91
Antibody Responses after Influenza Vaccination in Elderly People: Useful Information from a 27-Year Study (from 1988–1989 to 2014–2015) 82
Molecular analysis of Group of Rotaviruses detected in subjects with severe acute gastroenteritis in Umbria from 2006 to 2012 80
Audit clinico sull’impiego di plasma fresco congelato (PFC) in Umbria: disegno dello studio e risultati preliminari. 76
Annually repeated influenza vaccination and humoral response in elderly volunteers. 75
Clinical validation of a new algorithm for computerized dosing of vitamin K antagonist therapy: a retrospective simulation study. 73
An influenza A/H3 outbreak during the 2004/05 winter in elderly vaccinated people living in a nursing home. 69
Audit of the clinical use of fresh-frozen plasma in Umbria: study design and results of the pilot phase. 69
Critical appraisal of five international guidelines on fresh frozen plasma clinical use. 69
Influenza vaccination in patients on long-term anticoagulant therapy. 67
Immunogenicity of the MF-59-adjuvanted influenza vaccine in volunteers of different groups of age. 65
An influenza A/H3 outbreak during the 2004/2005 winter in elderlyvaccinated people living in a nursing home 64
Audit of the clinical use of fresh-frozen plasma in umbria: study design and results. 64
Antibody response against unchanged influenza vaccine components in elderly people vaccinated in consecutive years 62
Influenza vaccine immunogenicity and efficacy in istitutionalized elderly volunteers (winter season 2002/03). 61
An observational retrospective study provide information on hospitalization and severe outcomes of the 2009 A(H1N1) infection in Italy. 61
Antibody response elicited by 2012/2013 “implemented influenza vaccines”, FLUAD® (Novartis Vaccines & Diagnostics) and INTANZA® 15Mcg (Sanofi Pasteur MSD), in chronically ill institutionalized elderly volunteers 60
Induzione di risposta immunitaria e di protezione da parte dei vaccini antinfluenzali in soggetti anziani. 59
Differente risposta anticorpale al vaccine anti-influenzale per l’inverno 2008/2009 in soggetti anziani residenti in due differenti case di riposo. 59
Influenza vaccination in patients on long-term anticoagulant therapy 59
Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial. 58
Influenza vaccine induced antibody response against B influenza viruses included in the vaccine or naturally circulating during the winter season 2010/2011 55
Immunogenicity of conventional trivalent inactivated influenza vaccines in pre-vaccination unprotected elderly volunteers in five winters seasons. 54
Effects of repeated annual influenza vaccination on antibody responses against unchanged vaccine antigens in elderly frail institutionalized volunteers. 54
The good use of plasma. A critical analysis of five international guidelines. 54
Antibody responses to intradermal or intramuscular MF59-adjuvanted influenza vaccines as evaluated in elderly institutionalized volunteers during a season of partial mismatching between vaccine and circulatingA(H3N2)strains 54
Computer assisted vka monitoring with point of care device by general practitioners. 52
Clinical audit of the use of fresh frozen plasma in Umbria: study design and results of the pilot phase. 52
An influenza B outbreak during the 2007/2008 winter among appropriately immunized elderly people living in a nursing home. 51
Prospective assessment of clinical endpoints of vka treatment in a primary care computer assisted management model. 50
Induction of cross-reactive antibodies to 2009 pandemic H1N1 influenza virus (pH1N1) after seasonal vaccination (winters 2003/04 and 2007/08). 50
Comparative study on immunogenicity among split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 50
MF-59-adjuvanted influenza vaccine: immunogenicity and protection in adult and enderly volunteers (winter season 2003/04). 49
Pro-inflammatory cytokines/ chemokines production after infection of A549 Human epithelial cell line with different strains of human influenza viruses 49
Influenza vaccination and vitamin K antagonist treatment: a placebo-controlled, randomized, double-blind crossover study. 49
Hospitalization associated with 2009 pandemic influenza A(H1N1) infection in Umbria, a region of central Italy, July – December 2009. 48
Clinical characteristics of influenza A/H1N1, A/H3N2 and B infections in children during three consecutive winter seasons (2012-13, 2013-14 and 2014-15) 48
Induction of Cross-Reactive Antibodies to 2009 Pandemic H1N1 Influenza Virus (pH1N1) After Seasonal Vaccination (Winters 2003/04 and 2007/08) 48
Partial Protection Induced by 2011–2012 Influenza Vaccine Against Serologically Evidenced A(H3N2) Influenza Virus Infections in Elderly Institutionalized People 47
Immunogenicity of the MF-59-adjuvanted vaccine in volunteers of different group of age. 46
The intersubunit region of influenza virus haemagglutinin as a peptide vaccine candidate. 46
VALUTAZIONE DELL’EFFICACIA PROTETTIVA E DELLA CAPACITA’ DI INDURRE ANTICORPI CROSS-REATTIVI NEI CONFRONTI DI VIRUS INFLUENZALI DI TIPO B APPARTENENTI AI LINEAGGI YAMAGATA E VICTORIA DA PARTE DI DUE VACCINI INFLUENZALI TRIVALENTI (FLUAD® E INTANZA®) IN ANZIANI ISTITUZIONALIZZATI 46
Utilizzo di AGREE per l’analisi delle linee guida (LG) internazionali sul buon uso del plasma. 45
Preliminary survey of human intestinal parasitosis in a Peruvian Andean zone 44
Fresh Frozen Plasma Transfusion Practice: A Regional Benchmark Study. 44
Comparison of the BD Phoenix system with the cefoxitin disk diffusion test for detection of methicillin resistance in Staphylococcus aureus and coagulase-negative staphylococci. 44
CLINICAL AUDIT OF THE USE OF FRESH FROZEN PLASMA IN UMBRIA. 43
Seroprevalence against pandemic influenza A(H1N1) 2009 after the first season of circulation in Italy 42
COMPUTER ASSISTED VKA MONITORING WITH POINT OF CARE DEVICE BY GENERAL PRACTITIONERS. 42
Sorveglianza delle paralisi flaccide acute nella regione Umbria 42
Influenza vaccine induction of cross–reactive antibodies against different B/Yamagata and B/Victoria-like influenza viruses. , 41
Intradermal and intramuscular 2011-2012 influenza vaccination of elderly institutionalized volunteers: induction of antibody responses against vaccine and epidemic influenza virus strains 40
AUDIT OF THE CLINICAL USE OF FRESH-FROZEN PLASMA IN UMBRIA: STUDY DESIGN AND RESULTS. 39
Inhibitor development in mild/moderate haemophilia: could influenza vaccination have been the trigger? 39
Comparative study of immunogenicity of split, intradermal and MF59-adjuvanted influenza vaccines in elderly institutionalized subjects 39
Laboratory confirmed pandemic H1N1 influenza virus infections in hospitalization in Umbria, a region of central Italy (May-November 2009). 37
Soggetti ricoverati in ospedale in Umbria con diagnosi di laboratorio di infezione da virus influenzale pandemico A/H1N1 nel periodo Luglio 2009 - Marzo 2010 37
Seroprevalence to the 2009 pandemic influenza a(H1N1) virus in the italian population after the 2009 pandemic (September/November 2010) 36
INTERNATIONAL GUIDELINES ABOUT CLINICAL USE OF FRESH FROZEN PLASMA: A CRITICAL APPRAISAL. 36
INHIBITOR DEVELOPMENT IN MILD HAEMOPHILIA A: COULD INFLUENZA VACCINATION HAVE BEEN THE TRIGGER? 35
Immunogenicity of intramuscular MF59-adjuvanted and intradermal administered influenza enhanced vaccines in subjects aged over 60: A literature review 35
Sondaggio conoscitivo coproparassitologico in una zona andina della Cordillera Blanca, Peru'. 34
The new pandemic A/H1N1 influenza virus (pH1N1): celluler and humoral cross-reactive immune responses induced in healthy adults following 2007/2008 influenza vaccination. 33
The good use of plasma. A critical analysis of five international guidelines. 32
Il processo di validazione clinica di un algoritmo computerizzato per il monitoraggio della TAO 31
Influenza viruses and cross-reactivity in healthy adults: humoral and cellular immunity induced by seasonal 2007/2008 influenza vaccination against vaccine antigens and 2009 A(H1N1) pandemic influenza virus 31
Sorveglianza molecolare delle gastroenteriti da rotavirus in Umbria 29
ENDOGENOUS INTERLEUKYN-6 LEVELS AND ANTIBODY RESPONSE TO INACTIVATED INFLUENZA VACCINE IN PLURIVACCINATED ELDERLY VOLUNTEERS 26
PROSPECTIVE ASSESSMENT OF CLINICAL ENDPOINTS OF VKA TREATMENT IN A PRIMARY CARE COMPUTER ASSISTED MANAGEMENT MODEL 22
Serological evidence of partial protection against infection with A/H3N2 circulating drifted strains after immunization with enhanced 2011/2012 trivalent influenza vaccines 19
Totale 3.585
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.204
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.204
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020257 0 0 0 0 41 0 44 59 51 42 9 11
2020/2021664 14 51 6 56 183 14 56 4 50 11 50 169
2021/2022512 5 101 1 12 22 8 6 213 6 10 57 71
2022/20231.072 75 102 9 102 106 111 0 63 442 5 36 21
2023/2024438 28 42 28 9 3 0 141 20 39 5 63 60
2024/2025316 11 90 32 54 129 0 0 0 0 0 0 0
Totale 3.585